Food News and Research

RSS

IFR, PBL to further develop Dynamic Gastric Model

The Dynamic Gastric Model, developed from years of research at the Institute of Food Research, has taken significant steps towards improving its commercial use by food and drug companies worldwide.

26 Feb 2013

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.

26 Feb 2013

Examining potential changes to U.S. food aid programs

"There are rumors that U.S. food aid programs could see major changes in the next budget, including converting some of the Food for Peace program into straight cash grants instead of in-kind food assistance," Roger Thurow, senior fellow of global agriculture and food policy at the Chicago Council on Global Affairs, writes in the group's "Global Food for Thought" blog.

26 Feb 2013

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Complementary medicines include products containing herbs, vitamins, minerals, nutritional supplements, homoeopathic medicines, certain aromatherapy products and traditional Chinese medicines. For this reason they are also called herbal, natural or alternative medicines.

26 Feb 2013

Surefire Medical’s latest line of infusion system and specialty catheters receive CE Mark approval

Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced CE Mark approval for its Surefire Infusion System ST/LT and Surefire Specialty Catheters.

26 Feb 2013

Humanitarian groups warn of food shortages, lack of health care and education services in CAR

"Humanitarian agencies are warning of a looming food crisis in parts of the Central African Republic (CAR), a result of the insecurity that has displaced thousands of people and disrupted cultivation and trade," IRIN reports.

26 Feb 2013

Research roundup: Patients hesitant to focus on costs; Increase in primary care demand is uneven

One way to contain health care spending is to get patients involved in weighing costs of treatment options with their doctors. Researchers recruited 211 medically insured participants to assess their willingness to consider costs when choosing treatments. The authors found that participants generally "preferred better care, even when the relative benefit it offered was marginal, and even when told that the second-best choice still met the threshold of 'good enough' care from a clinician's perspective.

26 Feb 2013

NYAM initiative to create improved supports for New York's older adults during disasters

The New York Academy of Medicine (NYAM) has received $185,000 from The New York Community Trust and $100,000 from Altman Foundation to launch an initiative to create improved supports for New York's community-dwelling older adults before, during, and after disasters and other mass, long-term events, like power outages and heat waves.

26 Feb 2013

BIOTRONIK receives FDA approval for Lumax 740 DX System

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced the Food and Drug Administration (FDA) has granted final approval for the BIOTRONIK Lumax 740 DX System.

26 Feb 2013

LINX device may help relieve chronic heartburn symptoms

Clinical trial results published in the New England Journal of Medicine this week offer additional evidence that a new device may help relieve chronic heartburn symptoms that standard treatment cannot. The Keck Medical Center of USC was one of 14 U.S. and European medical centers to test the device prior to its March 2012 approval by the U.S. Food and Drug Administration.

26 Feb 2013

FDA approves Actavis’ generic Suboxone ANDA to treat opioid dependence

Actavis, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Buprenorphine HCl and Naloxone HCl Dihydrate SL Tablets, 2 mg/0.5 mg and 8 mg/2 mg, the generic equivalent to Reckitt Benckiser Healthcare's Suboxone.

26 Feb 2013

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to other FDA-approved treatments for this disease.

26 Feb 2013

Researchers to present new results for Merck's allergy immunotherapy tablets at AAAAI meeting

Merck, known as MSD outside the United States and Canada, today announced that researchers will present new data analyses of the safety and efficacy of the company's investigational allergy immunotherapy tablets (AITs) for ragweed pollen (Ambrosia artemisiifolia) and grass pollen (Phleum pratense) at the 2013 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting.

25 Feb 2013

Distinct bone marrow niches can nurture different types of blood stem cells

In research that could one day improve the success of stem cell transplants and chemotherapy, scientists have found that distinct niches exist in bone marrow to nurture different types of blood stem cells.

25 Feb 2013

GLP-1 may increase risk of hospitalization for people with acute pancreatitis

People who take the newest class of diabetes drugs to control blood sugar are twice as likely as those on other forms of sugar-control medication to be hospitalized with pancreatitis, Johns Hopkins researchers report.

25 Feb 2013

Non-surgical weight loss device clinical trial completes enrollment

ReShape Medical® Inc announced today that it has completed enrollment in the pivotal clinical trial for the ReShape Duo® Intragastric Balloon, one of the first non-surgical weight loss devices developed for the U.S. market.

25 Feb 2013

Comprehensive portfolio of antiretroviral products from Mylan

Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products.

25 Feb 2013

FDA alerts patients and health care providers of voluntary recall of Omontys by Affymax

The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all lots of Omontys Injection by Affymax, Inc., of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited, of Deerfield, Ill.

25 Feb 2013

New, effective and less toxic therapeutic option for patients with HER2-positive breast cancer

Patients with HER2-positive breast cancer, a particularly aggressive form of breast cancer, now have a new, effective and less toxic therapeutic option.

24 Feb 2013

Race and possibly genetics play a role in children's sensitivity to developing allergies

Research conducted at Henry Ford Hospital shows that race and possibly genetics play a role in children's sensitivity to developing allergies.

24 Feb 2013

Food News and Research

IFR, PBL to further develop Dynamic Gastric Model

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

Examining potential changes to U.S. food aid programs

Complementary medicine risks: an interview with Dr Andrew Boyden, NPS MedicineWise

Surefire Medical’s latest line of infusion system and specialty catheters receive CE Mark approval

Humanitarian groups warn of food shortages, lack of health care and education services in CAR

Research roundup: Patients hesitant to focus on costs; Increase in primary care demand is uneven

NYAM initiative to create improved supports for New York's older adults during disasters

BIOTRONIK receives FDA approval for Lumax 740 DX System

LINX device may help relieve chronic heartburn symptoms

FDA approves Actavis’ generic Suboxone ANDA to treat opioid dependence

Bayer receives FDA approval for Stivarga to treat advanced gastrointestinal stromal tumors

Researchers to present new results for Merck's allergy immunotherapy tablets at AAAAI meeting

Distinct bone marrow niches can nurture different types of blood stem cells

GLP-1 may increase risk of hospitalization for people with acute pancreatitis

Non-surgical weight loss device clinical trial completes enrollment

Comprehensive portfolio of antiretroviral products from Mylan

FDA alerts patients and health care providers of voluntary recall of Omontys by Affymax

New, effective and less toxic therapeutic option for patients with HER2-positive breast cancer

Race and possibly genetics play a role in children's sensitivity to developing allergies

The future is bioengineered: Synthetic biology and global sustainability eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News